Clinical efficacy of the essence oil of Zartaria multiflora on human liver hydatid cyst
Phase 1
- Conditions
- Hydatid disease (Hydatid cyst).
- Registration Number
- IRCT20180219038798N1
- Lead Sponsor
- Shiraz University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients who accepted the treatment protocol by signing the appropriate informed consent,
Patients with hepatic hydatid cysts smaller than 5 cm,
Patients with uncomplicated hydatid cysts (non calcified and non infected to bacterial infections),
Patients who were not simultaneously infected to pulmonary hydatid disease
Exclusion Criteria
Refusal of treatment at each stage of the treatment period
Patients with symptoms of complicated cysts (infection, abscessation).
Enlargement of the cysts during the course of treatment.
Adverse drug reactions leading to discontinuation of the treatment
Patients who don’t refer for periodic examinations and necessary tests
Recurrence of the disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the size of hydatid cysts. Timepoint: Before the start of treatment and after all treatment periods (totally 4 times). Method of measurement: By sonography.
- Secondary Outcome Measures
Name Time Method